CHEK2 and cancer: It will cover the mechanisms of Chk2 action, the role of Chk2 inhibitors in cancer treatment, their protective effects on non-cancerous cells during cancer therapy, and their therapeutic potential in treating HCV infections and neurodegenerative diseases.